BioSpace News Archive

Brooklyn ImmunoTherapeutics , a biopharmaceutical company focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, today announced the initiation of an open-label Phase 2 clinical trial of IRX-2 in combination with pembrolizumab (Keytruda ® ) and chemotherapy in triple negative breast cancer (TNBC). The trial will be conducted at the Providence Cancer Institute in Portland, Oreg

TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has been named a French Tech 120 company for the 2021 program.

Galecto, Inc. (NASDAQ: GLTO), a biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced Hans Schambye, the Company’s Chief Executive Officer, will participate in multiple upcoming investor conferences. Dr. Schambye and Jon Freve, the Company’s Chief Financial Officer, will be available for 1x1 meetings with investors at all meetings. Details are as follows: SVB Leerink 10 th Annual Global He

Reflect Scientific, Inc., a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, announces continued strong orders with an additional $231K in Cryometrix brand ultra-low temperature freezers.

-- Humanized IgG1 monoclonal antibody engineered to potently inhibit complement C3, with the potential for extended every eight-week dosing-- -- CATALINA Phase 2 study of NGM621 in patients with geographic atrophy (GA) currently underway

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will present at the BIO CEO & Investor Digital Conference that will take place virtually February 16 – 18, 2021.

InterShunt Technologies, Inc., an early-stage medical device company developing a novel catheter-based solution to reduce left atrial pressure in heart failure patients, announced today the appointment of key members to the company’s Board of Directors. Jim Bullock , David Adair , MD, MBA, and Denis Harrington

Epigenetics-based research tools and services company, Active Motif, Inc., announced that it has launched an end-to-end Hi-C service in partnership with Arima Genomics, Inc. to investigate the three-dimensional folding patterns of the genome, providing researchers with greater access to this powerful technology and advancing their research.

Apollo Medical Holdings, Inc., a leading physician-centric, technology-powered healthcare management company, announced it has appointed Chief Technology Officer Brandon Sim to the role of Chief Operating Officer, effective February 3, 2021.

Quotient Sciences , the drug development and manufacturing accelerator, announced that it has acquired Arcinova , the U.K.-based multiservice contract development and manufacturing organization (CDMO). With over 40 years of experience and 160 employees, Arcinova provides drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide.